Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer

Inflammation is a component of the tumor microenvironment and represents the 7th hallmark of cancer. Chronic inflammation plays a critical role in tumorigenesis. Tumor infiltrating inflammatory cells mediate processes associated with progression, immune suppression, promotion of neoangiogenesis and...

Full description

Saved in:
Bibliographic Details
Main Authors: Mario Orozco-Morales, Giovanny Soca-Chafre, Pedro Barrios-Bernal, Norma Hernández-Pedro, Oscar Arrieta
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2016/3494608
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850106555626684416
author Mario Orozco-Morales
Giovanny Soca-Chafre
Pedro Barrios-Bernal
Norma Hernández-Pedro
Oscar Arrieta
author_facet Mario Orozco-Morales
Giovanny Soca-Chafre
Pedro Barrios-Bernal
Norma Hernández-Pedro
Oscar Arrieta
author_sort Mario Orozco-Morales
collection DOAJ
description Inflammation is a component of the tumor microenvironment and represents the 7th hallmark of cancer. Chronic inflammation plays a critical role in tumorigenesis. Tumor infiltrating inflammatory cells mediate processes associated with progression, immune suppression, promotion of neoangiogenesis and lymphangiogenesis, remodeling of extracellular matrix, invasion and metastasis, and, lastly, the inhibition of vaccine-induced antitumor T cell response. Accumulating evidence indicates a critical role of myeloid cells in the pathophysiology of human cancers. In contrast to the well-characterized tumor-associated macrophages (TAMs), the significance of granulocytes in cancer has only recently begun to emerge with the characterization of tumor-associated neutrophils (TANs). Recent studies show the importance of CD47 in the interaction with macrophages inhibiting phagocytosis and promoting the migration of neutrophils, increasing inflammation which can lead to recurrence and progression in lung cancer. Currently, therapies are targeted towards blocking CD47 and enhancing macrophage-mediated phagocytosis. However, antibody-based therapies may have adverse effects that limit its use.
format Article
id doaj-art-2e3802bde1274bd48dbf433faaa96b1f
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-2e3802bde1274bd48dbf433faaa96b1f2025-08-20T02:38:48ZengWileyMediators of Inflammation0962-93511466-18612016-01-01201610.1155/2016/34946083494608Interplay between Cellular and Molecular Inflammatory Mediators in Lung CancerMario Orozco-Morales0Giovanny Soca-Chafre1Pedro Barrios-Bernal2Norma Hernández-Pedro3Oscar Arrieta4Experimental Oncology Laboratory, National Cancer Institute of Mexico (INCan), 14080 Mexico, DF, MexicoExperimental Oncology Laboratory, National Cancer Institute of Mexico (INCan), 14080 Mexico, DF, MexicoExperimental Oncology Laboratory, National Cancer Institute of Mexico (INCan), 14080 Mexico, DF, MexicoExperimental Oncology Laboratory, National Cancer Institute of Mexico (INCan), 14080 Mexico, DF, MexicoExperimental Oncology Laboratory, National Cancer Institute of Mexico (INCan), 14080 Mexico, DF, MexicoInflammation is a component of the tumor microenvironment and represents the 7th hallmark of cancer. Chronic inflammation plays a critical role in tumorigenesis. Tumor infiltrating inflammatory cells mediate processes associated with progression, immune suppression, promotion of neoangiogenesis and lymphangiogenesis, remodeling of extracellular matrix, invasion and metastasis, and, lastly, the inhibition of vaccine-induced antitumor T cell response. Accumulating evidence indicates a critical role of myeloid cells in the pathophysiology of human cancers. In contrast to the well-characterized tumor-associated macrophages (TAMs), the significance of granulocytes in cancer has only recently begun to emerge with the characterization of tumor-associated neutrophils (TANs). Recent studies show the importance of CD47 in the interaction with macrophages inhibiting phagocytosis and promoting the migration of neutrophils, increasing inflammation which can lead to recurrence and progression in lung cancer. Currently, therapies are targeted towards blocking CD47 and enhancing macrophage-mediated phagocytosis. However, antibody-based therapies may have adverse effects that limit its use.http://dx.doi.org/10.1155/2016/3494608
spellingShingle Mario Orozco-Morales
Giovanny Soca-Chafre
Pedro Barrios-Bernal
Norma Hernández-Pedro
Oscar Arrieta
Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
Mediators of Inflammation
title Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
title_full Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
title_fullStr Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
title_full_unstemmed Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
title_short Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
title_sort interplay between cellular and molecular inflammatory mediators in lung cancer
url http://dx.doi.org/10.1155/2016/3494608
work_keys_str_mv AT marioorozcomorales interplaybetweencellularandmolecularinflammatorymediatorsinlungcancer
AT giovannysocachafre interplaybetweencellularandmolecularinflammatorymediatorsinlungcancer
AT pedrobarriosbernal interplaybetweencellularandmolecularinflammatorymediatorsinlungcancer
AT normahernandezpedro interplaybetweencellularandmolecularinflammatorymediatorsinlungcancer
AT oscararrieta interplaybetweencellularandmolecularinflammatorymediatorsinlungcancer